Vetoquinol SA : Helped by a technical support level
Entry price | Target | Stop-loss | Potential |
---|
€81.4 |
€94 |
€75 |
+15.48% |
---|
The medium term support area around 77.4 EUR should allow Vetoquinol SA shares to re-establish an upward trend in the short term.
Strengths● The company is in a robust financial situation considering its net cash and margin position.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
● Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
● The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
● The company is not the most generous with respect to shareholders' compensation.
● For the past year, analysts have significantly revised downwards their profit estimates.
● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
● The average consensus view of analysts covering the stock has deteriorated over the past four months.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.